Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chao Hui Yang, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Chao Yang's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Chao Yang has written about over time.
Angiogenesis Inhibitors, 1 publications between 2014 and 2014, average publication date March 2014. Anti-Inflammatory Agents, 1 publications between 2014 and 2014, average publication date March 2014. Combined Modality Therapy, 1 publications between 2014 and 2014, average publication date March 2014. Cryoglobulinemia, 1 publications between 2014 and 2014, average publication date March 2014. Dexamethasone, 1 publications between 2014 and 2014, average publication date March 2014. Female, 1 publications between 2014 and 2014, average publication date March 2014. Glaucoma, Neovascular, 1 publications between 2014 and 2014, average publication date March 2014. Humans, 1 publications between 2014 and 2014, average publication date March 2014. Middle Aged, 1 publications between 2014 and 2014, average publication date March 2014. Plasmapheresis, 1 publications between 2014 and 2014, average publication date March 2014. Skin Ulcer, 1 publications between 2014 and 2014, average publication date March 2014. Thalidomide, 1 publications between 2014 and 2014, average publication date March 2014. Time Factors, 1 publications between 2014 and 2014, average publication date March 2014.

To see the data from this visualization as text, click here.
Yang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.